ASX - Delayed Quote • AUD AFT Pharmaceuticals Limited (AFP.AX) Follow Add holdings 2.5000 -0.0500 (-1.96%) At close: 3:47:52 PM GMT+10 All News Press Releases SEC Filings AFT Pharmaceuticals Limited (NZSE:AFT) insiders seem bullish, own 69% and have been buying more recently Key Insights AFT Pharmaceuticals' significant insider ownership suggests inherent interests in company's expansion 69... Is Weakness In AFT Pharmaceuticals Limited (NZSE:AFT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? It is hard to get excited after looking at AFT Pharmaceuticals' (NZSE:AFT) recent performance, when its stock has... AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 34% loss from investing in the stock three years ago For many investors, the main point of stock picking is to generate higher returns than the overall market. But its... Pleasing Signs As A Number Of Insiders Buy AFT Pharmaceuticals Stock When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase... With 69% ownership, AFT Pharmaceuticals Limited (NZSE:AFT) insiders have a lot riding on the company's future Key Insights Insiders appear to have a vested interest in AFT Pharmaceuticals' growth, as seen by their sizeable... Investors in AFT Pharmaceuticals (NZSE:AFT) have unfortunately lost 32% over the last three years For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any... Declining Stock and Solid Fundamentals: Is The Market Wrong About AFT Pharmaceuticals Limited (NZSE:AFT)? It is hard to get excited after looking at AFT Pharmaceuticals' (NZSE:AFT) recent performance, when its stock has... AFT Pharmaceuticals Limited (NZSE:AFT) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock? Investors in AFT Pharmaceuticals Limited ( NZSE:AFT ) had a good week, as its shares rose 2.1% to close at NZ$2.91... AFT Pharmaceuticals Full Year 2024 Earnings: EPS: NZ$0.15 (vs NZ$0.10 in FY 2023) AFT Pharmaceuticals ( NZSE:AFT ) Full Year 2024 Results Key Financial Results Revenue: NZ$195.4m (up 25% from FY 2023... Performance Overview Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) Return AFP.AX S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) YTD -1.96% -3.42% 1-Year +1.98% +7.93% 3-Year -16.21% +12.38%